Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice

Cheryl A Hill, Thomas E. Sussan, Roger H. Reeves, Joan T. Richtsmeier

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ts65Dn mice have segmental trisomy for orthologs of about half of the genes on human chromosome 21, including Ets2. These mice develop anomalies of the cranial skeleton and thymus that parallel those in Down syndrome. Overexpression of the Ets2 transcription factor gene was posited to be sufficient to produce these craniofacial and thymus deficits in transgenic mice that constitutively overexpress a processed Ets2 transcript under a promiscuous promoter [Sumarsono et al. (1996); Nature 379:534-537; Wolvetang et al. (2003); Hum Mol Genet 12:247-255]. Evaluation of trisomic mice with varying copy numbers of a properly regulated Ets2 gene indicated increased dosage of Ets2 was not sufficient to produce effects on thymus and most of the cranial anomalies seen in Ts65Dn mice. However, mesoderm-derived cranial skeletal elements are significantly more affected in Ts65Dn, Ets2+/- mice compared to Ts65Dn littermates suggesting a differential interaction of Ets2-related processes with mesoderm-derived and neural crest-derived formative tissues. Our results support the growing evidence for interactions among multiple genes contributing to developmental perturbations resulting in variation in complex Down syndrome phenotypes.

Original languageEnglish (US)
Pages (from-to)2158-2165
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume149
Issue number10
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Down Syndrome
Thymus Gland
Phenotype
Mesoderm
Genes
Viverridae
Chromosomes, Human, Pair 21
Neural Crest
Trisomy
Human Chromosomes
Skeleton
Transgenic Mice
Transcription Factors

Keywords

  • Craniofacial
  • Down syndrome
  • Ets2
  • Thymus
  • Ts65Dn

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. / Hill, Cheryl A; Sussan, Thomas E.; Reeves, Roger H.; Richtsmeier, Joan T.

In: American Journal of Medical Genetics, Part A, Vol. 149, No. 10, 10.2009, p. 2158-2165.

Research output: Contribution to journalArticle

Hill, Cheryl A ; Sussan, Thomas E. ; Reeves, Roger H. ; Richtsmeier, Joan T. / Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. In: American Journal of Medical Genetics, Part A. 2009 ; Vol. 149, No. 10. pp. 2158-2165.
@article{3acf0a0d8b0341a68106c2e588e169d4,
title = "Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic {"}Down syndrome{"} mice",
abstract = "Ts65Dn mice have segmental trisomy for orthologs of about half of the genes on human chromosome 21, including Ets2. These mice develop anomalies of the cranial skeleton and thymus that parallel those in Down syndrome. Overexpression of the Ets2 transcription factor gene was posited to be sufficient to produce these craniofacial and thymus deficits in transgenic mice that constitutively overexpress a processed Ets2 transcript under a promiscuous promoter [Sumarsono et al. (1996); Nature 379:534-537; Wolvetang et al. (2003); Hum Mol Genet 12:247-255]. Evaluation of trisomic mice with varying copy numbers of a properly regulated Ets2 gene indicated increased dosage of Ets2 was not sufficient to produce effects on thymus and most of the cranial anomalies seen in Ts65Dn mice. However, mesoderm-derived cranial skeletal elements are significantly more affected in Ts65Dn, Ets2+/- mice compared to Ts65Dn littermates suggesting a differential interaction of Ets2-related processes with mesoderm-derived and neural crest-derived formative tissues. Our results support the growing evidence for interactions among multiple genes contributing to developmental perturbations resulting in variation in complex Down syndrome phenotypes.",
keywords = "Craniofacial, Down syndrome, Ets2, Thymus, Ts65Dn",
author = "Hill, {Cheryl A} and Sussan, {Thomas E.} and Reeves, {Roger H.} and Richtsmeier, {Joan T.}",
year = "2009",
month = "10",
doi = "10.1002/ajmg.a.33012",
language = "English (US)",
volume = "149",
pages = "2158--2165",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice

AU - Hill, Cheryl A

AU - Sussan, Thomas E.

AU - Reeves, Roger H.

AU - Richtsmeier, Joan T.

PY - 2009/10

Y1 - 2009/10

N2 - Ts65Dn mice have segmental trisomy for orthologs of about half of the genes on human chromosome 21, including Ets2. These mice develop anomalies of the cranial skeleton and thymus that parallel those in Down syndrome. Overexpression of the Ets2 transcription factor gene was posited to be sufficient to produce these craniofacial and thymus deficits in transgenic mice that constitutively overexpress a processed Ets2 transcript under a promiscuous promoter [Sumarsono et al. (1996); Nature 379:534-537; Wolvetang et al. (2003); Hum Mol Genet 12:247-255]. Evaluation of trisomic mice with varying copy numbers of a properly regulated Ets2 gene indicated increased dosage of Ets2 was not sufficient to produce effects on thymus and most of the cranial anomalies seen in Ts65Dn mice. However, mesoderm-derived cranial skeletal elements are significantly more affected in Ts65Dn, Ets2+/- mice compared to Ts65Dn littermates suggesting a differential interaction of Ets2-related processes with mesoderm-derived and neural crest-derived formative tissues. Our results support the growing evidence for interactions among multiple genes contributing to developmental perturbations resulting in variation in complex Down syndrome phenotypes.

AB - Ts65Dn mice have segmental trisomy for orthologs of about half of the genes on human chromosome 21, including Ets2. These mice develop anomalies of the cranial skeleton and thymus that parallel those in Down syndrome. Overexpression of the Ets2 transcription factor gene was posited to be sufficient to produce these craniofacial and thymus deficits in transgenic mice that constitutively overexpress a processed Ets2 transcript under a promiscuous promoter [Sumarsono et al. (1996); Nature 379:534-537; Wolvetang et al. (2003); Hum Mol Genet 12:247-255]. Evaluation of trisomic mice with varying copy numbers of a properly regulated Ets2 gene indicated increased dosage of Ets2 was not sufficient to produce effects on thymus and most of the cranial anomalies seen in Ts65Dn mice. However, mesoderm-derived cranial skeletal elements are significantly more affected in Ts65Dn, Ets2+/- mice compared to Ts65Dn littermates suggesting a differential interaction of Ets2-related processes with mesoderm-derived and neural crest-derived formative tissues. Our results support the growing evidence for interactions among multiple genes contributing to developmental perturbations resulting in variation in complex Down syndrome phenotypes.

KW - Craniofacial

KW - Down syndrome

KW - Ets2

KW - Thymus

KW - Ts65Dn

UR - http://www.scopus.com/inward/record.url?scp=70349490080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349490080&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33012

DO - 10.1002/ajmg.a.33012

M3 - Article

C2 - 19764029

AN - SCOPUS:70349490080

VL - 149

SP - 2158

EP - 2165

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 10

ER -